Home/Filings/4/0001513935-17-000004
4//SEC Filing

ELLIE MAE INC 4

Accession 0001513935-17-000004

CIK 0001122388operating

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:24 PM ET

Size

19.3 KB

Accession

0001513935-17-000004

Insider Transaction Report

Form 4
Period: 2017-02-01
Luce Edgar
EVP, Finance & Admin, CFO
Transactions
  • Exercise/Conversion

    Common Stock

    2017-02-01$46.24/sh+700$32,36845,389 total
  • Exercise/Conversion

    Common Stock

    2017-02-01$19.60/sh+200$3,92044,889 total
  • Sale

    Common Stock

    2017-02-01$83.42/sh200$16,68544,689 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2017-02-012002,100 total
    Exercise: $19.60Exp: 2023-02-04Common Stock (200 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2017-02-017508,500 total
    Exercise: $24.93Exp: 2024-02-05Common Stock (750 underlying)
  • Sale

    Common Stock

    2017-02-01$83.42/sh700$58,39744,689 total
  • Exercise/Conversion

    Common Stock

    2017-02-01$24.93/sh+750$18,69845,439 total
  • Sale

    Common Stock

    2017-02-01$83.42/sh750$62,56844,689 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2017-02-0170010,462 total
    Exercise: $46.24Exp: 2025-02-11Common Stock (700 underlying)
Footnotes (6)
  • [F1]The exercise of these stock options was completed pursuant to the reporting person's Rule 10b5-1 trading plan.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions ranging from $83.0000 to $83.7100, inclusive. The reporting person undertakes to provide to Ellie Mae, Inc., any security holder of Ellie Mae, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F3]Option vests with respect to 25% of the shares subject thereto on February 4, 2014, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 4, 2017.
  • [F4]The reported transaction is a grant of a derivative security, in which we have left column 8 blank, and have reported the exercise or conversion price of the derivative security in column 2.
  • [F5]Option vests with respect to 25% of the shares subject thereto on February 5, 2015, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 5, 2018.
  • [F6]Option vests with respect to 25% of the shares subject thereto on February 11, 2016, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 11, 2019.

Issuer

ELLIE MAE INC

CIK 0001122388

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001122388

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:24 PM ET
Size
19.3 KB